The most critical event in the induction of most-immune responses is the activation of a resting CD4+ T cell by antigen. This step in the immune response appears to require not only the presentation of sufficient ligand for the T cell receptor but accessory signals as well. This step leads to the generation of both memory and effector T cells. This step in immune responses is very difficult to analyze in detail, as it has not been mimicked effectively in vitro, and is usually studied by in vivo priming with antigen. The goal of the present studies is to use anti-T cell receptor antibody as a substitute for antigen, and to characterize priming of T cells using a variety of detection systems, some of which may not require T cell proliferation. Four different types of information are being sought: First, can we define cell surface molecules, physical changes or intracellular events that define different stages of differentiation in CD4+ T cells, allowing us to place a given cell in a given activation state, and also allowing the measurement of transitions from one stats to another? Second, what are the requirements, both in terms of ligand and in terms of accessory cells or molecules derived from accessory cells, needed to drive a resting CD4+ T cell to memory or effector cells? Third, how do requirements for priming of D4+ T cells to become helper or inflammatory T cells differ? Finally, how do the activation requirements of T cells in different states of differentiation differ from one another, and what is the mechanism of this change? To carry out these studies, we will use monoclonal antibodies to the T cell receptor bound to cells or to plastic, or in soluble form, to stimulate resting or activated CD4+ T cells or cloned T cell lines representing different states of activation and different functional phenotypes, and compare activation requirements. Such assays will be used to identify and purify accessory cell molecules that contribute to in vitro priming. Monoclonal antibodies will be raised against these accessory cell factors and against cell surface molecules on cells in different states of activation so that we can accurately define activation state.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI026810-01
Application #
3140783
Study Section
Immunobiology Study Section (IMB)
Project Start
1989-01-01
Project End
1993-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
1
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Medzhitov, R; Janeway Jr, C A (1998) Innate immune recognition and control of adaptive immune responses. Semin Immunol 10:351-3
Janeway Jr, C A (1998) Presidential Address to The American Association of Immunologists. The road less traveled by: the role of innate immunity in the adaptive immune response. J Immunol 161:539-44
Medzhitov, R; Janeway Jr, C A (1998) An ancient system of host defense. Curr Opin Immunol 10:12-5
Medzhitov, R; Preston-Hurlburt, P; Kopp, E et al. (1998) MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2:253-8
Medzhitov, R; Janeway Jr, C A (1997) Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9:4-9
Chervonsky, A V; Wang, Y; Wong, F S et al. (1997) The role of Fas in autoimmune diabetes. Cell 89:17-24
Medzhitov, R; Janeway Jr, C A (1996) On the semantics of immune recognition. Res Immunol 147:208-14
Redoglia, V; Dianzani, U; Rojo, J M et al. (1996) Characterization of H4: a mouse T lymphocyte activation molecule functionally associated with the CD3/T cell receptor. Eur J Immunol 26:2781-9
Wolff, H; Janeway Jr, C (1994) Anti-CD45 augments response of a Th2 clone to TCR cross-linking. Scand J Immunol 40:22-5
Janeway Jr, C A; Bottomly, K (1994) Signals and signs for lymphocyte responses. Cell 76:275-85

Showing the most recent 10 out of 21 publications